ASP
CLVS

Adams Street Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Adams Street Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-18,785
Closed -$1.76M – 16
2017
Q2 		$1.76M Buy
+18,785
New +$1.15M 0.41% 8
2015
Q3 		– Sell
-41,610
Closed -$3.66M – 22
2015
Q2 		$3.66M Buy
+41,610
New +$3.56M 0.55% 7

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adams Street Partners's CLVS Position: Q3 2017 in Review

Adams Street Partners sold out of Clovis Oncology, Inc. (CLVS) in Q3 2017, closing a stake of 18,785 shares — an estimated $1.76M sold.

Adams Street Partners first reported a position in CLVS in Q2 2015 and held it in 2 quarters. The position peaked at $3.66M in Q2 2015. 255 funds tracked by Wall St. Rank hold CLVS as of Q3 2017.

  • Adams Street Partners reported no remaining Clovis Oncology, Inc. position as of Q3 2017 after selling out during the quarter.
  • Adams Street Partners sold 18,785 Clovis Oncology, Inc. shares in Q3 2017, an estimated $1.76M.
  • Adams Street Partners first reported a position in Clovis Oncology, Inc. in Q2 2015 and held it in 2 quarters.
  • Adams Street Partners's Clovis Oncology, Inc. position peaked at $3.66M in Q2 2015.
  • 255 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2017.

Based on Adams Street Partners's 13F filing for Q3 2017, filed 13 Nov 2017.